ID22643A - Steroid-steroid aktif secara antigestagenik dengan rantai 17 -alkilterfluorinasi - Google Patents
Steroid-steroid aktif secara antigestagenik dengan rantai 17 -alkilterfluorinasiInfo
- Publication number
- ID22643A ID22643A IDW990831A ID990831A ID22643A ID 22643 A ID22643 A ID 22643A ID W990831 A IDW990831 A ID W990831A ID 990831 A ID990831 A ID 990831A ID 22643 A ID22643 A ID 22643A
- Authority
- ID
- Indonesia
- Prior art keywords
- alkilterfluorination
- antigestagenic
- chain
- active steroids
- steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19706061A DE19706061A1 (de) | 1997-02-07 | 1997-02-07 | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
Publications (1)
Publication Number | Publication Date |
---|---|
ID22643A true ID22643A (id) | 1999-12-02 |
Family
ID=7820508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW990831A ID22643A (id) | 1997-02-07 | 1998-02-09 | Steroid-steroid aktif secara antigestagenik dengan rantai 17 -alkilterfluorinasi |
Country Status (35)
Country | Link |
---|---|
US (4) | US6316432B1 (id) |
EP (1) | EP0970103B1 (id) |
JP (1) | JP4324249B2 (id) |
KR (1) | KR100511815B1 (id) |
CN (2) | CN1246865A (id) |
AR (1) | AR010887A1 (id) |
AT (1) | ATE216397T1 (id) |
AU (1) | AU742834B2 (id) |
BG (1) | BG63875B1 (id) |
BR (1) | BR9807667A (id) |
CA (1) | CA2280041C (id) |
CL (1) | CL2004001191A1 (id) |
CZ (1) | CZ296328B6 (id) |
DE (2) | DE19706061A1 (id) |
DK (1) | DK0970103T3 (id) |
EA (1) | EA003092B1 (id) |
EE (1) | EE03831B1 (id) |
ES (1) | ES2175673T3 (id) |
HK (1) | HK1040718B (id) |
HU (1) | HUP0000968A3 (id) |
ID (1) | ID22643A (id) |
IL (1) | IL131226A (id) |
IS (1) | IS2190B (id) |
MY (1) | MY118508A (id) |
NO (1) | NO313554B1 (id) |
NZ (1) | NZ336989A (id) |
PL (1) | PL191808B1 (id) |
PT (1) | PT970103E (id) |
SI (1) | SI0970103T1 (id) |
SK (1) | SK283155B6 (id) |
TR (1) | TR199901855T2 (id) |
TW (1) | TW499434B (id) |
UA (1) | UA66783C2 (id) |
WO (1) | WO1998034947A1 (id) |
ZA (1) | ZA98985B (id) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
DE10049736A1 (de) * | 2000-09-29 | 2002-04-18 | Jenapharm Gmbh | 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
KR100632908B1 (ko) * | 2000-10-18 | 2006-10-13 | 쉐링 악티엔게젤샤프트 | 호르몬-의존성 질병의 예방 및 치료를 위한항프로게스틴의 용도 |
DE10051609A1 (de) * | 2000-10-18 | 2002-05-02 | Schering Ag | Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen |
UY26965A1 (es) * | 2000-10-18 | 2002-06-20 | Schering Ag | Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas |
UY26966A1 (es) * | 2000-10-18 | 2002-06-20 | Schering Ag | Uso de antiprogestinas para la inducción de apoptosis en una célula |
BR0114677A (pt) * | 2000-10-18 | 2003-10-07 | Schering Ag | Inibição da dependência de fator de crescimento de células de tumores |
ATE334683T1 (de) * | 2000-10-18 | 2006-08-15 | Schering Ag | Verwendung von 11beta-(4-acetylphenyl)-17beta- |
US20020143000A1 (en) * | 2001-01-09 | 2002-10-03 | Christa Hegele-Hartung | Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
EE200300321A (et) * | 2001-01-09 | 2003-10-15 | Schering Aktiengesellschaft | Antigestageenide kasutamine endomeetriumi kiirenenud küpsemise pärssimiseks viljatuse ravi ajal |
US20030013694A1 (en) * | 2001-05-25 | 2003-01-16 | Jens Hoffmann | Use and compositions of antiprogestins for treatment of prostate diseases |
UY27301A1 (es) * | 2001-05-25 | 2003-02-28 | Schering Ag | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata |
DE10159217A1 (de) | 2001-11-27 | 2003-06-05 | Schering Ag | 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate |
DE10221034A1 (de) | 2002-05-03 | 2003-11-20 | Schering Ag | 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
ATE307823T1 (de) * | 2002-05-03 | 2005-11-15 | Schering Ag | 17a-fluoralkyl-11beta-benzaldoxim-steroide, verfahren zu deren herstellung, diese steroide enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln |
US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
US7593347B2 (en) * | 2003-12-29 | 2009-09-22 | Intel Corporation | Method and apparatus to exchange channel information |
EP1862468A1 (de) | 2006-06-02 | 2007-12-05 | Bayer Schering Pharma Aktiengesellschaft | Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on |
DK3263112T3 (da) | 2006-10-24 | 2020-08-17 | Allergan Pharmaceuticals Int Ltd | Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer |
DE102006054535A1 (de) * | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesteronrezeptorantagonisten |
US20080268041A1 (en) * | 2007-04-23 | 2008-10-30 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases |
CA2683809A1 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen |
TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
EP2123279A1 (de) * | 2008-05-14 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Sequentielle Verabreichung von 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on und einem oder mehreren Gestagenen zur Behandlung gynäkologischer Erkrankungen |
US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034362A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
WO2011119194A1 (en) | 2010-03-22 | 2011-09-29 | Repros Therapeutics Inc. | Compositions and methods for non-toxic delivery of antiprogestins |
DE102010030538A1 (de) | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
DE102011004899A1 (de) | 2011-03-01 | 2012-09-06 | Bayer Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
US20130029953A1 (en) * | 2011-07-28 | 2013-01-31 | Klaus Nickisch | Progesterone antagonists |
DE102011087987A1 (de) | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
LT2983671T (lt) | 2013-04-11 | 2019-02-11 | Bayer Pharma Aktiengesellschaft | Progesterono receptoriaus antagonisto dozavimo forma |
US9096641B2 (en) | 2013-06-05 | 2015-08-04 | Evestra, Inc. | Imidazolyl progesterone antagonists |
EP2868323A1 (en) | 2013-11-03 | 2015-05-06 | Flamina Holding AG | A pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells |
EP2868321A1 (en) * | 2013-11-03 | 2015-05-06 | Flamina Holding AG | A composition or group of compositions for inhibiting autocrine HCG production in adult human cells |
MA42103A (fr) | 2015-05-18 | 2018-03-28 | Bayer Pharma AG | Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm) |
EP3214092A1 (en) | 2016-03-04 | 2017-09-06 | Bayer Pharma Aktiengesellschaft | Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE310541C (id) * | 1915-12-19 | 1919-01-30 | ||
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
FR2639045B2 (fr) | 1982-03-01 | 1994-07-29 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments |
US5064821A (en) * | 1982-11-18 | 1991-11-12 | Trustees Of Tufts College | Method and compositions for overcoming tetracycline resistance within living cells |
FR2598421B1 (fr) * | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
US5272140A (en) * | 1987-01-23 | 1993-12-21 | Akzo N.V. | 11-aryl steroid derivatives |
DE3723788A1 (de) * | 1987-07-16 | 1989-01-26 | Schering Ag | 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate |
DE3733478A1 (de) | 1987-10-01 | 1989-04-13 | Schering Ag | Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore |
BE1004905A4 (fr) * | 1987-12-30 | 1993-02-23 | Roussel Uclaf | Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
EP0369881A1 (fr) * | 1988-11-16 | 1990-05-23 | Roussel-Uclaf | Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments |
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
CN1055929C (zh) * | 1993-09-20 | 2000-08-30 | 中国科学院上海有机化学研究所 | 三氟甲基甾体化合物及其制备方法 |
DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
-
1997
- 1997-02-07 DE DE19706061A patent/DE19706061A1/de not_active Withdrawn
-
1998
- 1998-02-06 ZA ZA9800985A patent/ZA98985B/xx unknown
- 1998-02-06 MY MYPI98000482A patent/MY118508A/en unknown
- 1998-02-07 TW TW087101642A patent/TW499434B/zh not_active IP Right Cessation
- 1998-02-09 AU AU61005/98A patent/AU742834B2/en not_active Ceased
- 1998-02-09 TR TR1999/01855T patent/TR199901855T2/xx unknown
- 1998-02-09 UA UA99094999A patent/UA66783C2/xx unknown
- 1998-02-09 HU HU0000968A patent/HUP0000968A3/hu unknown
- 1998-02-09 CA CA002280041A patent/CA2280041C/en not_active Expired - Fee Related
- 1998-02-09 PL PL334878A patent/PL191808B1/pl not_active IP Right Cessation
- 1998-02-09 WO PCT/EP1998/000752 patent/WO1998034947A1/de active IP Right Grant
- 1998-02-09 EE EEP199900339A patent/EE03831B1/xx not_active IP Right Cessation
- 1998-02-09 ID IDW990831A patent/ID22643A/id unknown
- 1998-02-09 BR BR9807667-1A patent/BR9807667A/pt active Search and Examination
- 1998-02-09 DE DE59803856T patent/DE59803856D1/de not_active Expired - Lifetime
- 1998-02-09 AT AT98905419T patent/ATE216397T1/de active
- 1998-02-09 AR ARP980100532A patent/AR010887A1/es unknown
- 1998-02-09 ES ES98905419T patent/ES2175673T3/es not_active Expired - Lifetime
- 1998-02-09 SI SI9830200T patent/SI0970103T1/xx unknown
- 1998-02-09 EP EP98905419A patent/EP0970103B1/de not_active Expired - Lifetime
- 1998-02-09 IL IL13122698A patent/IL131226A/en not_active IP Right Cessation
- 1998-02-09 EA EA199900644A patent/EA003092B1/ru not_active IP Right Cessation
- 1998-02-09 CZ CZ0280599A patent/CZ296328B6/cs not_active IP Right Cessation
- 1998-02-09 KR KR10-1999-7007098A patent/KR100511815B1/ko not_active IP Right Cessation
- 1998-02-09 CN CN98802361A patent/CN1246865A/zh active Pending
- 1998-02-09 SK SK1038-99A patent/SK283155B6/sk not_active IP Right Cessation
- 1998-02-09 PT PT98905419T patent/PT970103E/pt unknown
- 1998-02-09 JP JP53378598A patent/JP4324249B2/ja not_active Expired - Fee Related
- 1998-02-09 DK DK98905419T patent/DK0970103T3/da active
- 1998-02-09 NZ NZ336989A patent/NZ336989A/en not_active IP Right Cessation
-
1999
- 1999-07-26 BG BG103603A patent/BG63875B1/bg unknown
- 1999-08-04 IS IS5147A patent/IS2190B/is unknown
- 1999-08-06 NO NO19993811A patent/NO313554B1/no not_active IP Right Cessation
-
2000
- 2000-03-01 US US09/516,359 patent/US6316432B1/en not_active Expired - Fee Related
- 2000-09-25 CN CNB001290150A patent/CN1202120C/zh not_active Expired - Fee Related
-
2001
- 2001-10-18 US US09/978,689 patent/US6503895B2/en not_active Expired - Fee Related
-
2002
- 2002-04-08 HK HK02102580.0A patent/HK1040718B/zh not_active IP Right Cessation
- 2002-11-27 US US10/304,742 patent/US6806263B2/en not_active Expired - Fee Related
-
2004
- 2004-05-20 CL CL200401191A patent/CL2004001191A1/es unknown
- 2004-09-24 US US10/948,652 patent/US7148213B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22643A (id) | Steroid-steroid aktif secara antigestagenik dengan rantai 17 -alkilterfluorinasi | |
NO994071D0 (no) | Epotilones med en modifisert sidekjede | |
IT1301781B1 (it) | Insieme a fibbia | |
DK199801565A (da) | En vindmølle | |
DE69826571D1 (de) | Dichtungsbüchse | |
DE69826770D1 (de) | Verbrennungsvorrichtung | |
NO980373D0 (no) | A/D omformingsapparat | |
FR2768938B1 (fr) | Raquette a neige | |
DE59805618D1 (de) | Lastverstelleinrichtung | |
DE69801856D1 (de) | Befestigungselement | |
DE69818559D1 (de) | Umreifungsmaschine | |
FR2768046B1 (fr) | Cotyle a bouchons | |
DE59809213D1 (de) | Greiferwebmaschine | |
FR2760375B1 (fr) | Raquette a neige | |
DK0905025T3 (da) | Omsnøringsapparat | |
FR2758387B1 (fr) | Four-tunnel a elements infra-rouge | |
NO995005L (no) | En ny fremgangsmåte | |
FR2767642B3 (fr) | Piege a cafards | |
NO985861L (no) | Bjelkelagselement | |
KR970059635U (ko) | 장구줄 조임구 | |
IT1304154B1 (it) | Insieme a fibbia | |
DE59806626D1 (de) | Greiferwebmaschine | |
DE59804524D1 (de) | Greiferwebmaschine | |
IT236441Y1 (it) | Valvola a farfalla | |
DK199900970A (da) | Tætningsarrangement |